ALK covalent inhibitor (West China Hospital/Guizhou Medical University/Xinxiang Medical University/Tsinghua University)

N/A

Report date: 2025/01/26 17:55:22
NME

Base Information

Drug NameALK covalent inhibitor (West China Hospital/Guizhou Medical University/Xinxiang Medical University/Tsinghua University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnaplastic lymphoma kinase inhibitors
TargetsAnaplastic lymphoma kinase
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWest China Hospital Of Sichuan University
China Registration ClassN/A

Develop Information

Active CompaniesGuizhou Medical UniversityXinxiang Medical UniversityWest China Hospital Of Sichuan University +[4] 
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A